Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Tenaya Therapeutics, Inc. Common Stock (TNYA)

Biological Products, (no Disgnostic Substances)

https://www.tenayatherapeutics.com

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

227,700,750

Shares Outstanding

68,110,000

Weighted SO

68,111,019

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

BCYC --.--%

IGMS --.--%

GLUE --.--%

STOK --.--%

BMEA --.--%

AKRO --.--%

FIXX --.--%

GOSS --.--%

RANI --.--%

Beta

2.4390

Last Div

0.0000

Range

1.66-7.01

Chg

-0.1000

Avg Vol

389848

Mkt Cap

227700750

Exch

NASDAQ

Country

US

Phone

650 825 6900

DCF Diff

2.4193

DCF

0.4507

Div Yield

0.0000

P/S

12.8907

EV Multiple

-1.5863

P/FV

1.8549

Div Yield %

0.0000

P/E

-2.0586

PEG

-0.0526

Payout

0.0000

Current Ratio

6.2846

Quick Ratio

6.2846

Cash Ratio

3.4786

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

153.9187

CCC

-153.9187

Gross Margin

0.4202

Op Margin

-7.1870

Pretax Margin

-6.8352

Net Margin

-6.8352

Eff Tax Rate

-0.0669

ROA

-0.7399

ROE

-0.8097

ROCE

-0.8667

NI/EBT

1.0000

EBT/EBIT

0.9511

EBIT/Rev

-7.1870

Debt Ratio

0.0954

D/E

0.1162

LT Debt/Cap

0.0835

Total Debt/Cap

0.1041

Int Coverage

0.0000

CF/Debt

-6.2826

Equity Multi

1.2178

Rec Turnover

0.0000

Pay Turnover

2.3714

Inv Turnover

0.0000

FA Turnover

0.3327

Asset Turnover

0.1082

OCF/Share

-1.1416

FCF/Share

-1.1537

Cash/Share

1.1586

OCF/Sales

-5.5389

FCF/OCF

1.0106

CF Coverage

-6.2826

ST Coverage

-29.0928

CapEx Coverage

-94.1665

Div&CapEx Cov

-94.1665

P/BV

1.8549

P/B

1.8549

P/S

12.8907

P/E

-2.0586

P/FCF

-2.3028

P/OCF

-2.5404

P/CF

-2.5404

PEG

-0.0526

P/S

12.8907

EV Multiple

-1.5863

P/FV

1.8549

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks GlobeNewswire Inc. Jan 03, 08:30 Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks GlobeNewswire Inc. Nov 21, 16:30 Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference GlobeNewswire Inc. Oct 26, 08:30 Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Revenue Product Segmentation